Prof.Dr.med. ID: 63635

Victor-Felix Mautner

graph of relations

Publications

  1. 2014
  2. Neuropathischer Schmerz ohne Neuropathie bei der Schwannomatose

    Farschtschi, S. C., Bäumer, P., Anna-Lena, H., Hauck, M., Gelderblom, M., Peter, G. & Mautner, V-F., 2014, 87. Kongress der Deutschen Gesellschaft für Neurologie mit Fortbildungsakademie.

    Research output: SCORING: Contribution to book/anthologyConference contribution - PosterResearch

  3. 2013
  4. Effects of pigment epithelium derived factor (PEDF) on malignant peripheral nerve sheath tumours (MPNSTs)

    Demestre, M., Terzi, M. Y., Mautner, V-F., Vajkoczy, P., Kurtz, A. & Piña, A. L., 01.12.2013, In: J NEURO-ONCOL. 115, 3, p. 391-9 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. Cardiac characterization of 16 patients with large NF1 gene deletions

    Nguyen, R., Mir, T. S., Kluwe, L., Jett, K., Kentsch, M., Müller, G., Kehrer-Sawatzki, H., Friedman, J. M. & Mautner, V-F., 01.10.2013, In: CLIN GENET. 84, 4, p. 344-349 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. Growth behavior of plexiform neurofibromas after surgery

    Nguyen, R., Ibrahim, C., Friedrich, R. E., Westphal, M., Schuhmann, M. & Mautner, V-F., 01.09.2013, In: GENET MED. 15, 9, p. 691-7 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  7. Evaluation of intratumoural heterogeneity on ¹⁸F-FDG PET/CT for characterization of peripheral nerve sheath tumours in neurofibromatosis type 1

    Salamon, J., Derlin, T., Bannas, P., Busch, J. D., Herrmann, J., Bockhorn, M., Hagel, C., Friedrich, R. E., Adam, G. & Mautner, V-F., 01.05.2013, In: EUR J NUCL MED MOL I. 40, 5, p. 685-92 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  8. Functional MHC class II is upregulated in neurofibromin-deficient Schwann cells

    Reuss, D. E., Mucha, J., Holtkamp, N., Müller, U., Berlien, H-P., Mautner, V-F., Ehemann, V., Platten, M., Scheffzek, K. & von Deimling, A., 01.05.2013, In: J INVEST DERMATOL. 133, 5, p. 1372-5 4 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  9. Merlin isoform 2 in neurofibromatosis type 2-associated polyneuropathy

    Schulz, A., Baader, S. L., Niwa-Kawakita, M., Jung, M. J., Bauer, R., Garcia, C., Zoch, A., Schacke, S., Hagel, C., Mautner, V-F., Hanemann, C. O., Dun, X-P., Parkinson, D. B., Weis, J., Schröder, J. M., Gutmann, D. H., Giovannini, M. & Morrison, H., 01.04.2013, In: NAT NEUROSCI. 16, 4, p. 426-33 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  10. Psychische Belastung von Erwachsenen mit Neurofibromatose Typ 1: Eine Längsschnittstudie

    Reichardt, C., Scherwath, A., Mautner, V-F., Bullinger-Naber, M. & Petersen-Ewert, C., 01.02.2013, In: PSYCHOTHER PSYCH MED. 63, 2, p. 85-92 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  11. Comparative effectiveness of 18F-FDG PET/CT versus whole-body MRI for detection of malignant peripheral nerve sheath tumors in neurofibromatosis type 1

    Derlin, T., Tornquist, K., Münster, S., Apostolova, I., Hagel, C., Friedrich, R. E., Wedegärtner, U. & Mautner, V-F., 01.01.2013, In: CLIN NUCL MED. 38, 1, p. e19-25

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  12. Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition

    Mohan, P., Castellsague, J., Jiang, J., Allen, K., Chen, H., Nemirovsky, O., Spyra, M., Hu, K., Kluwe, L., Pujana, M. A., Villanueva, A., Mautner, V-F., Keats, J. J., Dunn, S. E., Lazaro, C. & Maxwell, C. A., 01.01.2013, In: ONCOTARGET. 4, 1, p. 80-93 14 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  13. Lovastatin improves impaired synaptic plasticity and phasic alertness in patients with neurofibromatosis type 1

    Mainberger, F., Jung, N. H., Zenker, M., Wahlländer, U., Freudenberg, L., Langer, S., Berweck, S., Winkler, T., Straube, A., Heinen, F., Granström, S., Mautner, V-F., Lidzba, K. & Mall, V., 01.01.2013, In: BMC NEUROL. 13, p. 131

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  14. Sensitivity of malignant peripheral nerve sheath tumor cells to TRAIL is augmented by loss of NF1 through modulation of MYC/MAD and is potentiated by curcumin through induction of ROS

    Reuss, D. E., Mucha, J., Hagenlocher, C., Ehemann, V., Kluwe, L., Mautner, V-F. & von Deimling, A., 01.01.2013, In: PLOS ONE. 8, 2, p. e57152

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  15. Serum biomarkers for neurofibromatosis type 1 and early detection of malignant peripheral nerve-sheath tumors

    Park, S-J., Sawitzki, B., Kluwe, L., Mautner, V-F., Holtkamp, N. & Kurtz, A., 01.01.2013, In: BMC MED. 11, p. 109

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  16. Accumulation of non-compressive fascicular lesions underlies NF2 polyneuropathy.

    Bäumer, P., Mautner, V. F., Bäumer, T., Schuhmann, M. U., Tatagiba, M., Heiland, S., Kaestel, T., Bendszus, M. & Pham, M., 2013, In: J NEUROL. 260, 1, p. 38-46 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. B-scan ultrasonographic monitoring of orthotopic xenografted plexiform neurofibroma in mice

    Gleiss, J., Demestre, M., Spyra, M., Eschenhagen, T., Hagel, C., Mautner, V-F., Kluwe, L. & Friedrich, R. E., 2013, In: IN VIVO. 27, 6, p. 723-7 5 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  18. Comparability of 1.5T and 3.0T MRI-Volumetrics in Neurofibromatosis Type 1

    Farschtschi, S. C., Dombi, E., Widemann, B., Fünsterer, C. & Mautner, V-F., 2013, Annual Meeting of the Children's Tumor Foundation.

    Research output: SCORING: Contribution to book/anthologyConference contribution - PosterResearch

  19. Effect of vitamin D3 treatment on bone density in neurofibromatosis 1 patients: a retrospective clinical study.

    Schnabel, C., Jett, K., Friedman, J. M., Frieling, I., Kruse, H-P. & Mautner, V. F., 2013, In: JOINT BONE SPINE. 80, 3, p. 315-319 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  20. Plasma S100β is not a useful biomarker for tumor burden in neurofibromatosis.

    Smith, M. J., Esparza, S., Merker, V. L., Muzikansky, A., Bredella, M. A., Harris, G. J., Kassarjian, A., Cai, W., Walker, J. A., Mautner, V. F. & Plotkin, S. R., 2013, In: CLIN BIOCHEM. 46, 7-8, p. 698-700 7-8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  21. Response Of Spinal Ependymomas In Neurofibromatosis Type 2 to Bevacizumab - A Case Series

    Farschtschi, S. C., David, W., Blakeley, J. O., Merker, V. L., Plotkin, S. R., Schuhmann, M. & Mautner, V-F., 2013, Annual Meeting of the Children's Tumor Foundation.

    Research output: SCORING: Contribution to book/anthologyConference contribution - PosterResearch

  22. 2012
  23. Charakteristische Mikroläsionen bei Schwannomatose?

    Farschtschi, S. C., Bäumer, P., Pham, M., Bäumer, T. & Mautner, V-F., 09.2012, 85. Kongress der Deutschen Gesellschaft für Neurologie mit Fortbildungsakademie, CC Hamburg.

    Research output: SCORING: Contribution to book/anthologyConference contribution - PosterResearch

  24. Characterization of the nonallelic homologous recombination hotspot PRS3 associated with type-3 NF1 deletions.

    Zickler, A. M., Hampp, S., Messiaen, L., Bengesser, K., Mussotter, T., Roehl, A. C., Wimmer, K., Mautner, V. F., Kluwe, L., Upadhyaya, M., Pasmant, E., Chuzhanova, N., Kestler, H. A., Högel, J., Legius, E., Claes, K., Cooper, D. N. & Kehrer-Sawatzki, H., 2012, In: HUM MUTAT. 33, 2, p. 372-383 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  25. Clinical presentation, immunohistochemistry and electron microscopy indicate neurofibromatosis type 2-associated gliomas to be spinal ependymomas.

    Hagel, C., Stemmer-Rachamimov, A. O., Bornemann, A., Schuhmann, M., Nagel, C., Huson, S., Evans, D. G., Plotkin, S., Matthies, C., Kluwe, L. & Mautner, V. F., 2012, In: NEUROPATHOLOGY. 32, 6, p. 611-616 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  26. Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2.

    Blakeley, J. O., Evans, D. G., Adler, J., Brackmann, D., Chen, R., Ferner, R. E., Hanemann, C. O., Harris, G., Huson, S. M., Jacob, A., Kalamarides, M., Karajannis, M. A., Korf, B. R., Mautner, V. F., McClatchey, A. I., Miao, H., Plotkin, S. R., Slattery, W., Stemmer-Rachamimov, A. O., Welling, D. B., Wen, P. Y., Widemann, B., Hunter-Schaedle, K. & Giovannini, M., 2012, In: AM J MED GENET A. 158A, 1, p. 24-41 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  27. Dissecting the clinical phenotype associated with mosaic type-2 NF1 microdeletions.

    Kehrer-Sawatzki, H., Vogt, J., Mußotter, T., Kluwe, L., Cooper, D. N. & Mautner, V. F., 2012, In: NEUROGENETICS. 13, 3, p. 229-236 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  28. Growth dynamics of plexiform neurofibromas: a retrospective cohort study of 201 patients with neurofibromatosis 1.

    Nguyen, R., Dombi, E., Widemann, B. C., Solomon, J., Fuensterer, C., Kluwe, L., Friedman, J. M. & Mautner, V. F., 2012, In: ORPHANET J RARE DIS. 7, p. 75

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  29. Hybrid neurofibroma/schwannoma is overrepresented among schwannomatosis and neurofibromatosis patients.

    Harder, A., Wesemann, M., Hagel, C., Schittenhelm, J., Fischer, S., Tatagiba, M., Nagel, C., Jeibmann, A., Bohring, A., Mautner, V. F. & Paulus, W., 2012, In: AM J SURG PATHOL. 36, 5, p. 702-709 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  30. Identification of recurrent type-2 NF1 microdeletions reveals a mitotic nonallelic homologous recombination hotspot underlying a human genomic disorder.

    Vogt, J., Mussotter, T., Bengesser, K., Claes, K., Högel, J., Chuzhanova, N., Fu, C., van den Ende, J., Mautner, V. F., Cooper, D. N., Messiaen, L. & Kehrer-Sawatzki, H., 2012, In: HUM MUTAT. 33, 11, p. 1599-1609 11.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  31. Impaired Pten expression in human malignant peripheral nerve sheath tumours.

    Bradtmöller, M., Hartmann, C., Zietsch, J., Jäschke, S., Mautner, V. F., Kurtz, A., Park, S-J., Baier, M., Harder, A., Reuss, D., von Deimling, A., Heppner, F. L. & Holtkamp, N., 2012, In: PLOS ONE. 7, 11, p. 47595 11.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  32. Internal tumor burden in neurofibromatosis Type I patients with large NF1 deletions.

    Kluwe, L., Nguyen, R., Vogt, J., Bengesser, K., Mussotter, T., Friedrich, R., Jett, K., Kehrer-Sawatzki, H. & Mautner, V. F., 2012, In: GENE CHROMOSOME CANC. 51, 5, p. 447-451 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  33. Microarray-based copy number analysis of neurofibromatosis type-1 (NF1)-associated malignant peripheral nerve sheath tumors reveals a role for Rho-GTPase pathway genes in NF1 tumorigenesis.

    Upadhyaya, M., Spurlock, G., Thomas, L., Thomas, N. S. T., Richards, M., Mautner, V. F., Cooper, D. N., Guha, A. & Yan, J., 2012, In: HUM MUTAT. 33, 4, p. 763-776 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  34. Molecular heterogeneity in malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1.

    Thomas, L., Mautner, V. F., Cooper, D. N. & Upadhyaya, M., 2012, In: HUM GENOMICS. 6, p. 18

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  35. Multiple orbital neurofibromas, painful peripheral nerve tumors, distinctive face and marfanoid habitus: a new syndrome.

    Babovic-Vuksanovic, D., Messiaen, L., Nagel, C., Brems, H., Scheithauer, B., Denayer, E., Mao, R., Sciot, R., Janowski, K. M., Schuhmann, M. U., Claes, K., Beert, E., Garrity, J. A., Spinner, R. J., Stemmer-Rachamimov, A., Gavrilova, R., Frank, V. C., Mautner, V. F. & Legius, E., 2012, In: EUR J HUM GENET. 20, 6, p. 618-625 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  36. Non-coding RNA ANRIL and the number of plexiform neurofibromas in patients with NF1 microdeletions.

    Mußotter, T., Kluwe, L., Högel, J., Nguyen, R., Cooper, D. N., Mautner, V. F. & Kehrer-Sawatzki, H., 2012, In: BMC MED GENET. 13, p. 98

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  37. Overactivation of Ras signaling pathway in CD133+ MPNST cells.

    Borrego-Diaz, E., Terai, K., Lialyte, K., Wise, A. L., Esfandyari, T., Behbod, F., Mautner, V. F., Spyra, M., Taylor, S., Parada, L. F., Upadhyaya, M. & Farassati, F., 2012, In: J NEURO-ONCOL. 108, 3, p. 423-434 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  38. Psychological burden in adult neurofibromatosis type 1 patients: impact of disease visibility on body image.

    Granström, S., Langenbruch, A. K., Augustin, M. & Mautner, V. F., 2012, In: DERMATOLOGY. 224, 2, p. 160-167 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  39. Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosis.

    Plotkin, S. R., Bredella, M. A., Cai, W., Kassarjian, A., Harris, G. J., Esparza, S., Merker, V. L., Munn, L. L., Muzikansky, A., Askenazi, M., Nguyen, R., Wenzel, R. & Mautner, V. F., 2012, In: PLOS ONE. 7, 4, p. 35711 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  40. The adverse influence of attention-deficit disorder with or without hyperactivity on cognition in neurofibromatosis type 1.

    Lidzba, K., Granström, S., Lindenau, J. & Mautner, V. F., 2012, In: DEV MED CHILD NEUROL. 54, 10, p. 892-897 10.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  41. Tissue-specific differences in the proportion of mosaic large NF1 deletions are suggestive of a selective growth advantage of hematopoietic del(+/-) stem cells.

    Roehl, A. C., Mussotter, T., Cooper, D. N., Kluwe, L., Wimmer, K., Högel, J., Zetzmann, M., Vogt, J., Mautner, V. F. & Kehrer-Sawatzki, H., 2012, In: HUM MUTAT. 33, 3, p. 541-550 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  42. Value of Whole Body MRI in patients with NF1

    Mautner, V-F., 2012, Neurofibromatosis Type 1: Molecular and Cellular Biology. Heidelberg: Springer, p. 84-91 83 p. 7

    Research output: SCORING: Contribution to book/anthologySCORING: Contribution to collected editions/anthologiesResearchpeer-review

  43. Whole-body MRI in neurofibromatosis: incidental findings and prevalence of scoliosis.

    Jaremko, J. L., MacMahon, P. J., Torriani, M., Merker, V. L., Mautner, V. F., Plotkin, S. R. & Bredella, M. A., 2012, In: SKELETAL RADIOL. 41, 8, p. 917-923 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  44. 2011
  45. Plexiform neurofibromas in children with neurofibromatosis type 1: frequency and associated clinical deficits.

    Nguyen, R., Kluwe, L., Fuensterer, C., Kentsch, M., Friedrich, R. & Mautner, V. F., 01.10.2011, In: J PEDIATR-US. 159, 4, p. 652-652 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  46. Podoplanin and CD34 in peripheral nerve sheath tumours: focus on neurofibromatosis 1-associated atypical neurofibroma.

    Naber, U., Friedrich, R., Glatzel, M., Mautner, V. F. & Hagel, C., 01.06.2011, In: J NEURO-ONCOL. 103, 2, p. 239-245 7 p., 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  47. Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors.

    Beert, E., Brems, H., Daniëls, B., Ivo, D. W., Frank, V. C., Schoenaers, J., Debiec-Rychter, M., Gevaert, O., Thomas, D. R., Annick, V. D. B., de Ravel, T., Cichowski, K., Kluwe, L., Mautner, V. F., Sciot, R. & Legius, E., 2011, In: GENE CHROMOSOME CANC. 50, 12, p. 1021-1032 12.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  48. Cancer stem cell-like cells derived from malignant peripheral nerve sheath tumors.

    Spyra, M., Kluwe, L., Hagel, C., Nguyen, R., Panse, J., Kurtz, A., Mautner, V. F., Rabkin, S. D. & Demestre, M., 2011, In: PLOS ONE. 6, 6, p. 21099 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  49. Clinical and healthcare status of patients with neurofibromatosis type 1.

    Langenbruch, A. K., Augustin, M., Granström, S., Kluwe, L. & Mautner, V. F., 2011, In: BRIT J DERMATOL. 165, 1, p. 225-227 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  50. Delineation of the clinical phenotype associated with non-mosaic type-2 NF1 deletions: two case reports.

    Vogt, J., Nguyen, R., Kluwe, L., Schuhmann, M., Roehl, A. C., Mußotter, T., Cooper, D. N., Mautner, V. F. & Kehrer-Sawatzki, H., 2011, In: J MED CASE REP. 5, 1, p. 577 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  51. Effects of splicing mutations on NF2-transcripts: transcript analysis and information theoretic predictions.

    Ellis, J. R., Heinrich, B., Mautner, V. F. & Kluwe, L., 2011, In: GENE CHROMOSOME CANC. 50, 8, p. 571-584 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  52. MIA is a potential biomarker for tumour load in neurofibromatosis type 1.

    Kolanczyk, M., Mautner, V. F., Kossler, N., Nguyen, R., Kühnisch, J., Zemojtel, T., Jamsheer, A., Wegener, E., Thurisch, B., Tinschert, S., Holtkamp, N., Park, S-J., Birch, P., Kendler, D., Harder, A., Mundlos, S. & Kluwe, L., 2011, In: BMC MED. 9, p. 82

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  53. Monozygotic twins discordant for neurofibromatosis type 1 due to a postzygotic NF1 gene mutation.

    Vogt, J., Kohlhase, J., Morlot, S., Kluwe, L., Mautner, V. F., Cooper, D. N. & Kehrer-Sawatzki, H., 2011, In: HUM MUTAT. 32, 6, p. 2134-2147 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  54. 2010
  55. Radiographic regression of vestibular schwannomas induced by bevacizumab treatment: sustain under continuous drug application and rebound after drug discontinuation.

    Mautner, V. F., Nguyen, R., Knecht, R. & Bokemeyer, C., 01.11.2010, In: ANN ONCOL. 21, 11, p. 2294-2295 2 p., 11.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review